SCHEMBL7989876

SCHEMBL7989876

COc1ccc(C(=O)Nc2ccc3c(c2)CN(C)CC3(C)C)cc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ROCK2 O75116 5/20 0.47
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
BRAF P15056 10/20 0.46
RAF1 P04049 1/20 0.46
CYP3A4 P08684 1/20 0.45
NPC1 O15118 1/20 0.45
POLB P06746 1/20 0.45
RAB9A P51151 1/20 0.45
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652847 0.93 ROCK2 (0.46) MAPTTP53THRBSMN1; SMN2ROCK2
SCHEMBL7652080 0.92 DDR1 (0.43) MAPTTP53THRBSMN1; SMN2ROCK2
Hydrochloric Acid SCHEMBL7657621 0.91 DDR1 (0.42) MAPTTP53THRBSMN1; SMN2ROCK2
SCHEMBL7661973 0.90 BRAF (0.46) MAPTTP53THRBSMN1; SMN2ROCK2
SCHEMBL7653791 0.90 MAPT (0.45) MAPTTP53SMN1; SMN2ROCK2KDM4E
Hydrochloric Acid SCHEMBL7654827 0.89 BRAF (0.45) MAPTTP53THRBSMN1; SMN2ROCK2
SCHEMBL7652814 0.87 NAMPT (0.55) ROCK2KDM4ECYP3A4NPC1POLB
SCHEMBL7657373 0.87 RAB9A (0.41) MAPTTP53THRBSMN1; SMN2ROCK2
SCHEMBL7652898 0.86 KIT (0.49) BRAF
SCHEMBL7658686 0.85 KMT2A (0.53) MAPTSMN1; SMN2ROCK2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US claimed
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US disclosed
EP-0971897-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2000-01-19 EP disclosed
WO-1998041507-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 1998-09-24 WO disclosed